Astera Labs (NASDAQ:ALAB) Stock Price Down 5.7% – Here’s Why

Astera Labs, Inc. (NASDAQ:ALAB)’s share price fell 5.7% during mid-day trading on Tuesday . The stock traded as low as $276.68 and last traded at $279.91. Approximately 3,385,477 shares changed hands during trading, a decline of 37% from the average session volume of 5,336,723 shares. The stock had previously closed at $296.98.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on the company. Citigroup reissued a “buy” rating on shares of Astera Labs in a report on Wednesday, July 29th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. JPMorgan Chase & Co. lifted their target price on shares of Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a report on Wednesday, May 6th. Stifel Nicolaus boosted their target price on shares of Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Finally, TD Cowen lowered their price target on shares of Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a report on Wednesday, August 5th. One research analyst has rated the stock with a Strong Buy rating, twelve have issued a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $348.33.

Astera Labs Stock Performance

The company has a 50 day moving average price of $334.67 and a 200 day moving average price of $252.89. The firm has a market cap of $47.56 billion, a price-to-earnings ratio of 135.71 and a beta of 3.77.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, August 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.69 by $0.11. The company had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.Astera Labs’s revenue was up 104.5% compared to the same quarter last year. During the same period in the previous year, the company posted $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts forecast that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

Insider Activity

In other Astera Labs news, Director Manuel Alba sold 136,974 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $442.01, for a total transaction of $60,543,877.74. Following the sale, the director owned 1,287,524 shares in the company, valued at $569,098,483.24. This represents a 9.62% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, General Counsel Philip Mazzara sold 6,801 shares of the stock in a transaction dated Monday, August 17th. The shares were sold at an average price of $340.50, for a total value of $2,315,740.50. Following the completion of the sale, the general counsel directly owned 96,542 shares in the company, valued at $32,872,551. This represents a 6.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 396,745 shares of company stock worth $155,029,458 over the last three months. Company insiders own 10.40% of the company’s stock.

Institutional Investors Weigh In On Astera Labs

Hedge funds and other institutional investors have recently modified their holdings of the company. Royal Bank of Canada raised its stake in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock valued at $9,097,000 after buying an additional 95,409 shares in the last quarter. AQR Capital Management LLC increased its holdings in shares of Astera Labs by 213.4% in the 1st quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock valued at $680,000 after acquiring an additional 7,756 shares during the last quarter. Empowered Funds LLC raised its position in shares of Astera Labs by 917.3% during the 1st quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after acquiring an additional 4,183 shares in the last quarter. First Trust Advisors LP raised its position in shares of Astera Labs by 102.0% during the 2nd quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after acquiring an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. lifted its stake in Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock worth $505,000 after purchasing an additional 1,977 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors and hedge funds.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.